Top

Published in:

29-07-2023 | Heart Failure

The Association Between Intra-abdominal Pressure and Diuretic Response in Heart Failure

Authors: S. Crespo-Aznarez, A. Campos-Sáenz de Santamaría, M. Sánchez-Marteles, V. Garcés-Horna, C. Josa-Laorden, I. Giménez-López, J. I. Pérez-Calvo, J. Rubio-Gracia

Published in: Current Heart Failure Reports | Issue 5/2023

Abstract

Purpose of the Review

An efficient diuretic response is vital during cardiac decompensation in heart failure (HF) patients. The increase in intra-abdominal pressure (IAP) could be one of the keys for understanding cardiorenal syndrome and guiding diuretic treatment during hospitalization. In this review, we analyze the relationship between IAP and diuretic response in HF patients.

Recent Findings

Increased IAP is associated with worsening renal function (WRF) in patients with advanced HF. Furthermore, the persistence of a rise in IAP after the first 72 h of intravenous diuretic treatment has been correlated with a worse diuretic response, a higher degree of congestion, and an impaired prognosis.

Summary

The rise in IAP in HF patients has been associated with impaired renal function and a lower diuretic response. Nonetheless, more studies are needed to elucidate the actual role of IAP in congestive nephropathy and whether it may help guide diuretic therapy during acute decompensations.

Available only for authorised users

Trullàs JC, Pérez-Calvo JI, Conde-Martel A, Llàcer Iborra P, Suárez Pedreira I, Ormaechea G, et al. Epidemiology of heart failure with preserved ejection fraction: results from the RICA Registry. Med Clin (Barc). 2021;157(1):1–9. https://doi.org/10.1016/j.medcli.2020.05.059.CrossRefPubMed

Farmakis D, Parissis J, Lekakis J, Filippatos G. Acute heart failure: epidemiology, risk factors, and prevention. Rev Esp Cardiol (Engl Ed). 2015;68(3):245–8. https://doi.org/10.1016/j.rec.2014.11.004.CrossRefPubMed

Sayago-Silva I, García-López F, Segovia-Cubero J. Epidemiology of heart failure in Spain over the last 20 years. Rev Esp Cardiol (Engl Ed). 2013;66(8):649–56. https://doi.org/10.1016/j.rec.2013.03.012.CrossRefPubMed

Dharmarajan K, Rich MW. Epidemiology, pathophysiology, and prognosis of heart failure in older adults. Heart Fail Clin. 2017;13(3):417–26. https://doi.org/10.1016/j.hfc.2017.02.001.CrossRefPubMed

Sánchez-Marteles M, Rubio-Gracia J, Giménez-López I. Pathophysiology of acute heart failure: a world to know. Rev Clin Esp (Barc). 2016;216(1):38–46. https://doi.org/10.1016/j.rce.2015.09.010.CrossRefPubMed

Rubio-Gracia J, Sánchez-Marteles M, Pérez-calvo JI. Congestion in heart failure, a prominent role in pathophysiology, and a therapeutic goal. Span J Med. 2021;1:35–45. https://doi.org/10.24875/SJMED.M21000001.CrossRef

Boorsma EM, Ter Maaten JM, Damman K, Dinh W, Gustafsson F, Goldsmith S, et al. Congestion in heart failure: a contemporary look at physiology, diagnosis and treatment. Nat Rev Cardiol. 2020;17(10):641–55. https://doi.org/10.1038/s41569-020-0379-7.CrossRefPubMed

Núñez J, de la Espriella R, Rossignol P, Voors AA, Mullens W, Metra M, et al. Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology [published correction appears in Eur J Heart Fail. 2023 Mar;25(3):443]. Eur J Heart Fail. 2022;24(10):1751–66. https://doi.org/10.1002/ejhf.2664.CrossRefPubMed

Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. AHA/ACC/HFSA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2022;145(18):e876–94. https://doi.org/10.1161/CIR.0000000000001062.CrossRefPubMed

10.

Lala A, McNulty SE, Mentz RJ, Dunlay SM, Vader JM, AbouEzzeddine OF, et al. Relief and recurrence of congestion during and after hospitalization for acute heart failure: insights from diuretic optimization strategy evaluation in acute decompensated heart failure (DOSE-AHF) and cardiorenal rescue study in acute decompensated heart failure (CARESS-HF). Circ Heart Fail. 2015;8(4):741–8. https://doi.org/10.1161/CIRCHEARTFAILURE.114.001957.CrossRefPubMedPubMedCentral

11.

Ambrosy AP, Pang PS, Khan S, Konstam MA, Fonarow GC, Traver B, et al. Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial. Eur Heart J. 2013;34(11):835–43. https://doi.org/10.1093/eurheartj/ehs444.CrossRefPubMed

12.•

Rubio-Gracia J, Demissei BG, Ter Maaten JM, Cleland JG, O'Connor CM, Metra M, et al. Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure. Int J Cardiol. 2018;258:185–91. https://doi.org/10.1016/j.ijcard.2018.01.067. In this article, Rubio et al, demonstrated that one-third of ADHF patients had persistent clinical congestion at discharge, a situation related to worse outcomes. Furthermore, the authors identified independent predictors linked to poor diuretic response residual congestion.CrossRefPubMed

13.

Damman K, Testani JM. The kidney in heart failure: an update. Eur Heart J. 2015;36(23):1437–44. https://doi.org/10.1093/eurheartj/ehv010.CrossRefPubMedPubMedCentral

14.

Mullens W, Damman K, Testani JM, Martens P, Mueller C, Lassus J, et al. Evaluation of kidney function throughout the heart failure trajectory - a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2020;22(4):584–603. https://doi.org/10.1002/ejhf.1697.CrossRefPubMed

15.

Sanchez-Serna J, Hernandez-Vicente A, Garrido-Bravo IP, Pastor-Perez F, Noguera-Velasco JA, Casas-Pina T, et al. Impact of pre-hospital renal function on the detection of acute kidney injury in acute decompensated heart failure. Eur J Intern Med. 2020;77:66–72. https://doi.org/10.1016/j.ejim.2020.02.028.CrossRefPubMed

16.•

JPE L, Nieminen MS, Peuhkurinen K, Pulkki K, Siirilä-Waris K, Sund R, et al. Markers of renal function and acute kidney injury in acute heart failure: definitions and impact on outcomes of the cardiorenal syndrome. Eur Heart J. 2010;31(22):2791–8. https://doi.org/10.1093/eurheartj/ehq293. This article is basic to understand the importance of renal function in heart failure and how to interpret renal function changes during HF decompensations.CrossRef

17.

Ronco C, Cicoira M, McCullough PA. Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure. J Am Coll Cardiol. 2012;60(12):1031–42. https://doi.org/10.1016/j.jacc.2012.01.077.CrossRefPubMed

18.

Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol. 2008;52(19):1527–39. https://doi.org/10.1016/j.jacc.2008.07.051.CrossRefPubMed

19.

Hopper I, Kotecha D, Chin KL, Mentz RJ, von Lueder TG. Comorbidities in heart failure: are there gender differences? Curr Heart Fail Rep. 2016;13(1):1–12. https://doi.org/10.1007/s11897-016-0280-1.CrossRefPubMed

20.

Pérez-Calvo JI, Josa-Laorden C, Rubio-Gracia J, Giménez-López I. Comorbidities in heart failure with mid-range ejection fraction. Eur J Intern Med. 2017;41:e27–8. https://doi.org/10.1016/j.ejim.2017.02.010.CrossRefPubMed

21.

Ruiz-Laiglesia FJ, Sánchez-Marteles M, Pérez-Calvo JI, Formiga F, Bartolomé-Satué JA, Armengou-Arxé A, et al. Comorbidity in heart failure. Results of the Spanish RICA Registry. QJM. 2014;107(12):989–94. https://doi.org/10.1093/qjmed/hcu127.CrossRefPubMed

22.•

Damman K, MAE V, Voors AA, O’Connor CM, Van Veldhuisen DJ, Hillege HL. Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. Eur Heart J. 2014;35(7):455–69. https://doi.org/10.1093/eurheartj/eht386. This meta-analysis is the largest study were renal function has demonstrated it’s prognostic impact in HF patients. Due to these results, cardiorenal interactions are now an important topic under investigation.CrossRefPubMed

23.

Kuroda S, Damman K, ter Maaten JM, Voors AA, Okumura T, Kida K, et al. Very early diuretic response after admission for acute heart failure. J Card Fail. 2019;25(1):12–9. https://doi.org/10.1016/j.cardfail.2018.09.004.CrossRefPubMed

24.

Valente MAE, Voors AA, Damman K, Van Veldhuisen DJ, Massie BM, O’Connor CM, et al. Diuretic response in acute heart failure: clinical characteristics and prognostic significance. Eur Heart J. 2014;35(19):1284–93. https://doi.org/10.1093/eurheartj/ehu065.CrossRefPubMed

25.

Ter Maaten JM, Valente MAE, Damman K, Hillege HL, Navis G, Voors AA. Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy. Nat Rev Cardiol. 2015;12(3):184–92. https://doi.org/10.1038/nrcardio.2014.215.CrossRefPubMed

26.

Ter Maaten JM, Dunning AM, Valente MAE, Damman K, Ezekowitz JA, Califf RM, et al. Diuretic response in acute heart failure-an analysis from ASCEND-HF. Am Heart J. 2015;170(2):313–21. https://doi.org/10.1016/j.ahj.2015.05.003.CrossRefPubMed

27.

Ter Maaten JM, Valente MAE, Damman K, Cleland JG, Givertz MM, Metra M, et al. Combining diuretic response and hemoconcentration to predict rehospitalization after admission for acute heart failure. Circ Heart Fail. 2016;9(6):e002845. https://doi.org/10.1161/CIRCHEARTFAILURE.115.002845.CrossRefPubMed

28.

Aronson D, Abassi Z, Allon E, Burger AJ. Fluid loss, venous congestion, and worsening renal function in acute decompensated heart failure. Eur J Heart Fail. 2013;15(6):637–43. https://doi.org/10.1093/eurjhf/hft036.CrossRefPubMed

29.

Afsar B, Ortiz A, Covic A, Solak Y, Goldsmith D, Kanbay M. Focus on renal congestion in heart failure. Clin Kidney J. 2016;9(1):39–47. https://doi.org/10.1093/ckj/sfv124.CrossRefPubMed

30.

Rubio Gracia J, Sánchez Marteles M, Pérez Calvo JI. Involvement of systemic venous congestion in heart failure. Rev Clin Esp (Barc). 2017;217(3):161–9. https://doi.org/10.1016/j.rce.2016.10.012.CrossRefPubMed

31.

Dupont M, Mullens W, Tang WH. Impact of systemic venous congestion in heart failure. Curr Heart Fail Rep. 2011;8(4):233–41. https://doi.org/10.1007/s11897-011-0071-7.CrossRefPubMed

32.

Colombo PC, Onat D, Harxhi A, Demmer RT, Hayashi Y, Jelic S, et al. Peripheral venous congestion causes inflammation, neurohormonal, and endothelial cell activation. Eur Heart J. 2014;35(7):448–54. https://doi.org/10.1093/eurheartj/eht456.CrossRefPubMed

33.

Testani JM, Damman K. Venous congestion and renal function in heart failure ... it's complicated. Eur J Heart Fail. 2013;15(6):599–601. https://doi.org/10.1093/eurjhf/hft060.CrossRefPubMed

34.

Gnanaraj JF, Von Haehling S, Anker SD, Raj DS, Radhakrishnan J. The relevance of congestion in the cardio-renal syndrome. Kidney Int. 2013;83(3):384–91. https://doi.org/10.1038/ki.2012.406.CrossRef

35.

Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC, et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol. 2009;53(7):589–96. https://doi.org/10.1016/j.jacc.2008.05.068.CrossRefPubMedPubMedCentral

36.

Damman K, Voors AA, Hillege HL, Navis G, Lechat P, Van Veldhuisen DJ, et al. Congestion in chronic systolic heart failure is related to renal dysfunction and increased mortality. Eur J Heart Fail. 2010;12(9):974–82. https://doi.org/10.1093/eurjhf/hfq118.CrossRefPubMed

37.

Shiga T, Suzuki A, Haruta S, Mori F, Ota Y, Yagi M, et al. Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan. ESC Heart Fail. 2019;6(3):475–86. https://doi.org/10.1002/ehf2.12418.CrossRefPubMedPubMedCentral

38.

Lazzeri C, Valente S, Tarquini R, Gensini GF. Cardiorenal syndrome caused by heart failure with preserved ejection fraction. Int J Nephrol. 2011;2011:634903. https://doi.org/10.4061/2011/634903.CrossRefPubMedPubMedCentral

39.

Lam CSP, Voors AA, de Boer RA, Solomon SD, van Veldhuisen DJ. Heart failure with preserved ejection fraction: from mechanisms to therapies [published correction appears in Eur Heart J. 2019 Feb 7;40(6):528]. Eur Heart J. 2018;39(30):2780–92. https://doi.org/10.1093/eurheartj/ehy301.CrossRefPubMed

40.

Wattad M, Darawsha W, Solomonica A, Hijazi M, Kaplan M, Makhoul BF, et al. Interaction between worsening renal function and persistent congestion in acute decompensated heart failure. Am J Cardiol. 2015;115(7):932–7. https://doi.org/10.1016/j.amjcard.2015.01.019.CrossRefPubMed

41.

Angelini A, Castellani C, Virzì GM, Fedrigo M, Thiene G, Valente M, et al. The role of congestion in cardiorenal syndrome type 2: new pathophysiological insights into an experimental model of heart failure. Cardiorenal Med. 2015;6(1):61–72. https://doi.org/10.1159/000440775.CrossRefPubMedPubMedCentral

42.

Metra M, Davison B, Bettari L, Sun H, Edwards C, Lazzarini V, et al. Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. Circ Heart Fail. 2012;5(1):54–62. https://doi.org/10.1161/CIRCHEARTFAILURE.111.963413.CrossRefPubMed

43.•

Damman K, van Deursen VM, Navis G, Voors AA, van Veldhuisen DJ, Hillege HL. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol. 2009;53(7):582–8. https://doi.org/10.1016/j.jacc.2008.08.080. Retrospective analysis of a large cohort of chronic HF patients who were explored by right catheterization. The authors concluded that central venous pressure was an independent predictor factor of impaired renal function, on top of hypotension. The results focus on the importance of congestion as an independent physiopatological mechanism link to impaired renal function in HF.CrossRefPubMed

44.•

Husain-Syed F, Gröne HJ, Assmus B, Bauer P, Gall H, Seeger W, et al. Congestive nephropathy: a neglected entity? Proposal for diagnostic criteria and future perspectives. ESC Heart Fail. 2021;8(1):183–203. https://doi.org/10.1002/ehf2.13118. In this article, the authors propose standard definitions for congestive nephropathy and suggest future research questions to update knowledge in this area.CrossRefPubMed

45.

Abu-Saleh N, Aronson D, Khamaisi M, Khoury EE, Awad H, Kabala A, et al. Increased intra-abdominal pressure induces acute kidney injury in an experimental model of congestive heart failure. J Card Fail. 2019;25(6):468–78. https://doi.org/10.1016/j.cardfail.2019.03.008.CrossRefPubMed

46.

Willassen Y, Ofstad J. Intrarenal venous and cortical catheter pressures in the dog kidney. Scand J Clin Lab Invest. 1979;39(8):697–705. https://doi.org/10.1080/00365517909108160.CrossRefPubMed

47.

Nguyen VQ, Gadiraju TV, Patel H, Park M, Le Jemtel TH, Jaiswal A. Intra-abdominal hypertension: an important consideration for diuretic resistance in acute decompensated heart failure. Clin Cardiol. 2016;39(1):37–40. https://doi.org/10.1002/clc.22489.CrossRefPubMed

48.

Malbrain MLNG, Cheatham ML, Kirkpatrick A, Sugrue M, Parr M, De Waele J, et al. Results from the international conference of experts on intra-abdominal hypertension and abdominal compartment syndrome. I. Definitions. Intensive Care Med. 2006;32(11):1722–32. https://doi.org/10.1007/s00134-006-0349-5.CrossRefPubMed

49.

Zymliński R, Biegus J, Sokolski M, Jankowska EA, Banasiak W, Ponikowski P. Validation of transurethral intra-abdominal pressure measurement in acute heart failure. Pol Arch Intern Med. 2018;128(6):403–5. https://doi.org/10.20452/pamw.4290.CrossRefPubMed

50.

Malbrain MLNG, De Laet I, De Waele JJ, Sugrue M, Schachtrupp A, Duchesne J, et al. The role of abdominal compliance, the neglected parameter in critically ill patients - a consensus review of 16. Part 2: measurement techniques and management recommendations. Anaesthesiol Intensive Ther. 2014;46(5):406–32. https://doi.org/10.5603/AIT.2014.0063.CrossRefPubMed

51.•

Verbrugge FH, Dupont M, Steels P, Grieten L, Malbrain M, WHW T, et al. Abdominal contributions to cardiorenal dysfunction in congestive heart failure. J Am Coll Cardiol. 2013;62(6):485–95. https://doi.org/10.1016/j.jacc.2013.04.070. Positioning paper were Verbrugge FH et al review the important role of increased intraabdominal pressure, abdominal congestion and organ dysfunction in HF patients.CrossRefPubMed

52.

Mohmand H, Goldfarb S. Renal dysfunction associated with intra-abdominal hypertension and the abdominal compartment syndrome. J Am Soc Nephrol. 2011;22(4):615–21. https://doi.org/10.1681/ASN.2010121222.CrossRefPubMed

53.•

Mullens W, Abrahams Z, Skouri HN, Francis GS, Taylor DO, Starling RC, et al. Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function? J Am Coll Cardiol. 2008;51(3):300–6. https://doi.org/10.1016/j.jacc.2007.09.043. Unicentrical and observational study that associated for the first time the role of increased intraabdominal pressure on impaired renal function and worsening renal function of patients with severe left ventricle dysfunction.CrossRefPubMed

54.

Boorsma EM, ter Maaten JM, Voors AA, van Veldhuisen DJ. Renal compression in heart failure: the renal tamponade hypothesis. JACC Heart Fail. 2022;10(3):175–83. https://doi.org/10.1016/j.jchf.2021.12.005.CrossRefPubMed

55.•

Rubio-Gracia J, Giménez-López I, Sánchez-Marteles M, Josa-Laorden C, Pérez-Calvo JI. Intra-abdominal pressure and its relationship with markers of congestion in patients admitted for acute decompensated heart failure. Heart Vessels. 2020;35(11):1545–56. https://doi.org/10.1007/s00380-020-01634-9. Observational study in non-critical HF patients that identified the absence of significant intraabdominal pressure reduction at 48 h to a higher prevalence of all-cause mortality and HF re-hospitalizations.CrossRefPubMed

56.

Mullens W, Abrahams Z, Francis GS, Taylor DO, Starling RC, Tang WH. Prompt reduction in intra-abdominal pressure following large-volume mechanical fluid removal improves renal insufficiency in refractory decompensated heart failure. J Card Fail. 2008;14(6):508–14. https://doi.org/10.1016/j.cardfail.2008.02.010.CrossRefPubMed

57.

Rubio-Gracia J, Giménez-López I, Damman K, Sánchez-Marteles M, Garcés-Horna V, Josa-Laorden C, et al. Intraabdominal pressure and worsening renal function during decompensations of heart failure. A preliminary report from the PIA study. Rev Clin Esp (Barc). 2019;219(5):229–35. https://doi.org/10.1016/j.rce.2018.09.022.CrossRefPubMed

58.

Rubio Gracia J, Giménez López I, Josa Laorden C, Sánchez Marteles M, Garcés Horna V, de la Rica Escuín ML, et al. Variation in intraabdominal pressure in patients with acute heart failure according to left ventricular ejection fraction. Results of an intraabdominal pressure study. Rev Clin Esp (Barc). 2021;221(7):384–92. https://doi.org/10.1016/j.rceng.2020.01.011.CrossRefPubMed

59.

Wijayaratne D, Muthuppalaniappan VM, Davenport A. Serum CA125 a potential marker of volume status for peritoneal dialysis patients? Int J Artif Organs. 2021;44(12):1029–33. https://doi.org/10.1177/03913988211016862.CrossRefPubMedPubMedCentral

60.

Núñez J, Bayés-Genís A, Revuelta-López E, ter Maaten JM, Miñana G, Barallat J, et al. Clinical role of CA125 in worsening heart failure: A BIOSTAT-CHF study subanalysis. JACC Heart Fail. 2020;8(5):386–97. https://doi.org/10.1016/j.jchf.2019.12.005.CrossRefPubMed

61.

Josa-laorden C, Giménez-López I, Butcher C, Sánchez-Marteles S, Rubio-Gracia J, et al. Prognostic value of glycoprotein CA125 and their time-line changes in decompensated heart failure. Span J Med. 2021;1:1–11. https://doi.org/10.24875/SJMED.M21000008.CrossRef

62.

Núñez-Marín G, de la Espriella R, Santas E, Lorenzo M, Miñana G, Núñez E, et al. CA125 but not NT-proBNP predicts the presence of a congestive intrarenal venous flow in patients with acute heart failure; 2021. https://doi.org/10.1093/ehjacc/zuab022.CrossRef

63.•

Rubio-Gracia J, Crespo-Aznarez S, De la Espriella R, Nuñez G, Sánchez-Marteles M, Garcés-Horna V, et al. Utility of plasma CA125 as a proxy of intra-abdominal pressure in patients with acute heart failure. Eur Heart J Acute Cardiovasc Care. 2022;11(6):453–60. https://doi.org/10.1093/ehjacc/zuac046. Observational study were CA125, a biomarker of tissular congestion, was identified as a marker of abdominal congestion (increase intraabdominal pressure).CrossRefPubMed

64.

Marini C, Fragasso G, Italia L, Sisakian H, Tufaro V, Ingallina G, et al. Lung ultrasound-guided therapy reduces acute decompensation events in chronic heart failure. Heart. 2020;106(24):1934–9. https://doi.org/10.1136/heartjnl-2019-316429.CrossRefPubMed

65.

Curbelo J, Rodriguez-Cortes P, Aguilera M, Gil-Martinez P, Martín D, Suarez FC. Comparison between inferior vena cava ultrasound, lung ultrasound, bioelectric impedance analysis, and natriuretic peptides in chronic heart failure. Curr Med Res Opin. 2019;35(4):705–13. https://doi.org/10.1080/03007995.2018.1519502.CrossRefPubMed

66.

Araiza-Garaygordobil D, Gopar-Nieto R, Martinez-Amezcua P, Cabello-López A, Alanis-Estrada G, Luna-Herbert A, et al. A randomized controlled trial of lung ultrasound-guided therapy in heart failure (CLUSTER-HF study). Am Heart J. 2020;227:31–9. https://doi.org/10.1016/j.ahj.2020.06.003.CrossRefPubMed

67.

Rivas-Lasarte M, Álvarez-García J, Fernández-Martínez J, Maestro A, López-López L, Solé-González E, et al. Lung ultrasound-guided treatment in ambulatory patients with heart failure: a randomized controlled clinical trial (LUS-HF study). Eur J Heart Fail. 2019;21(12):1605–13. https://doi.org/10.1002/ejhf.1604.CrossRefPubMed

68.

Burgos LM, Baro Vila R, Goyeneche A, Muñoz F, Spaccavento A, Fasan MA, et al. Design and rationale of the inferior vena CAVA and Lung UltraSound-guided therapy in Acute Heart Failure (CAVAL US-AHF Study): a randomised controlled trial. Open. Heart. 2022;9(2):e002105. https://doi.org/10.1136/openhrt-2022-002105.CrossRef

69.

Spevack R, Al Shukairi M, Jayaraman D, Dankoff J, Rudski L, Lipes J. Serial lung and IVC ultrasound in the assessment of congestive heart failure. Crit Ultrasound J. 2017;9(1):7. https://doi.org/10.1186/s13089-017-0062-3.CrossRefPubMedPubMedCentral

70.

Koratala A, Reisinger N. Venous excess doppler ultrasound for the nephrologist: pearls and pitfalls. Kidney Med. 2022;4(7):100482. https://doi.org/10.1016/j.xkme.2022.100482.CrossRefPubMedPubMedCentral

71.

Soliman-Aboumarie H, Denault AY. How to assess systemic venous congestion with point of care ultrasound. Eur Heart J Cardiovasc Imaging. 2023;24(2):177–80. https://doi.org/10.1093/ehjci/jeac239.CrossRefPubMed

72.

Torres Macho J, García Sánchez FJ, Garmilla Ezquerra P, Beltrán Romero L, Canora Lebrato J, Casas Rojo JM, et al. Positioning document on incorporating point-of-care ultrasound in Internal Medicine departments. Rev Clin Esp (Barc). 2018;218(4):192–8. https://doi.org/10.1016/j.rce.2018.02.001.CrossRefPubMed

73.

Pellicori P, Shah P, Cuthbert J, Urbinati A, Zhang J, Kallvikbacka-Bennett A, et al. Prevalence, pattern and clinical relevance of ultrasound indices of congestion in outpatients with heart failure. Eur J Heart Fail. 2019;21(7):904–16. https://doi.org/10.1002/ejhf.1383.CrossRefPubMed

74.

Hacıalioğulları F, Yılmaz F, Yılmaz A, Sönmez BM, Demir TA, Karadaş MA, et al. Role of point-of-care lung and inferior vena cava ultrasound in clinical decisions for patients presenting to the emergency department with symptoms of acute decompensated heart failure. J Ultrasound Med. 2021;40(4):751–61. https://doi.org/10.1002/jum.15447.CrossRefPubMed

75.

Picano E, Pellikka PA. Ultrasound of extravascular lung water: a new standard for pulmonary congestion. Eur Heart J. 2016;37(27):2097–104. https://doi.org/10.1093/eurheartj/ehw164.CrossRefPubMedPubMedCentral

76.

Bauman Z, Coba V, Gassner M, Amponsah D, Gallien J, Blyden D, et al. Inferior vena cava collapsibility loses correlation with internal jugular vein collapsibility during increased thoracic or intra-abdominal pressure. J Ultrasound. 2015;18(4):343–8. https://doi.org/10.1007/s40477-015-0181-2.CrossRefPubMedPubMedCentral

77.

Josa-Laorden C, Giménez-López I, Rubio-Gracia J, Ruiz-Laiglesia F, Garcés-Horna V, Pérez-Calvo JI. Valor pronóstico de la medición del diámetro y colapso inspiratorio de la vena cava inferior en la insuficiencia cardiaca aguda [Prognostic value of measuring the diameter and inspiratory collapse of the inferior vena cava in acute heart failure]. Rev Clin Esp (Barc). 2016;216(4):183–90. https://doi.org/10.1016/j.rce.2015.11.012.CrossRefPubMed

78.

Khandwalla RM, Birkeland KT, Zimmer R, Henry TD, Nazarian R, Sudan M, et al. Usefulness of serial measurements of inferior vena cava diameter by VscanTM to identify patients with heart failure at high risk of hospitalization. Am J Cardiol. 2017;119(10):1631–6. https://doi.org/10.1016/j.amjcard.2017.02.007.CrossRefPubMed

79.

Torres-Macho J, Cerqueiro-González JM, Arévalo-Lorido JC, Llácer-Iborra P, Cepeda-Rodrigo JM, Cubo-Romano P, et al. The effects of a therapeutic strategy guided by lung ultrasound on 6-month outcomes in patients with heart failure: results from the EPICC randomized controlled trial. J Clin Med. 2022;11(16):4930. https://doi.org/10.3390/jcm11164930.CrossRefPubMedPubMedCentral

80.•

Beaubien-Souligny W, Rola P, Haycock K, Bouchard J, Lamarche Y, Spiegel R, et al. Quantifying systemic congestion with point-of-care ultrasound: development of the venous excess ultrasound grading system. Ultrasound J. 2020;12(1):16. https://doi.org/10.1186/s13089-020-00163-w. In this article, venous excess ultrasound (VeXus) was described for the first time. It is a basic paper to better understand the implications of congestion in venous hemodynamics.CrossRefPubMedPubMedCentral

81.

Rola P, Miralles-Aguiar F, Argaiz E, Beaubien-Souligny W, Haycock K, Karimov T, et al. Clinical applications of the venous excess ultrasound (VExUS) score: conceptual review and case series. Ultrasound J. 2021;13(1):32. https://doi.org/10.1186/s13089-021-00232-8.CrossRefPubMedPubMedCentral

82.

Trpkov C, Grant ADM, Fine NM. Intrarenal doppler ultrasound renal venous stasis index correlates with acute cardiorenal syndrome in patients with acute decompensated heart failure. CJC Open. 2021;3(12):1444–52. https://doi.org/10.1016/j.cjco.2021.07.010.CrossRefPubMedPubMedCentral

83.

Stevenson LW, Perloff JK. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA. 1989;261(6):884–8. https://doi.org/10.1001/jama.1989.03420060100040.CrossRefPubMed

84.

Damy T, Kallvikbacka-Bennett A, Zhang J, Goode K, Buga L, Hobkirk J, et al. Does the physical examination still have a role in patients with suspected heart failure? Eur J Heart Fail. 2011;13(12):1340–8. https://doi.org/10.1093/eurjhf/hfr128.CrossRefPubMed

85.

Selvaraj S, Claggett B, Pozzi A, McMurray JJV, Jhund PS, Packer M, et al. Prognostic implications of congestion on physical examination among contemporary patients with heart failure and reduced ejection fraction: PARADIGM-HF. Circulation. 2019;140(17):1369–79. https://doi.org/10.1161/CIRCULATIONAHA.119.039920.CrossRefPubMed

86.

Llàcer P, Gallardo MÁ, Palau P, Moreno MC, Castillo C, Fernández C, et al. Comparison between CA125 and NT-proBNP for evaluating congestion in acute heart failure. Comparación entre CA125 y NT-proBNP para valorar la congestión en insuficiencia cardíaca aguda. Med Clin (Barc). 2021;156(12):589–94. https://doi.org/10.1016/j.medcli.2020.05.063.CrossRefPubMed

87.

Torres-Arrese M, Mata-Martínez A, Luordo-Tedesco D, García-Casasola G, Alonso-González R, Montero-Hernández E, et al. Usefulness of systemic venous ultrasound protocols in the prognosis of heart failure patients: results from a prospective multicentric study. J Clin Med. 2023;12(4):1281. https://doi.org/10.3390/jcm12041281.CrossRefPubMedPubMedCentral

88.

Kirkpatrick AW, Roberts DJ, De Waele J, Jaeschke R, Malbrain MLNG, De Keulenaer B, et al. Intra-abdominal hypertension and the abdominal compartment syndrome: updated consensus definitions and clinical practice guidelines from the World Society of the Abdominal Compartment Syndrome. Intensive Care Med. 2013;39(7):1190–206. https://doi.org/10.1007/s00134-013-2906-z.CrossRefPubMedPubMedCentral

89.

Van Damme L, De Waele JJ. Effect of decompressive laparotomy on organ function in patients with abdominal compartment syndrome: a systematic review and meta-analysis. Crit Care. 2018;22(1):179. https://doi.org/10.1186/s13054-018-2103-0.CrossRefPubMedPubMedCentral

90.

Stevens PE, Levin A. Kidney disease: improving global outcomes chronic kidney disease guideline development work group members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825–30. https://doi.org/10.7326/0003-4819-158-11-201306040-00007.CrossRefPubMed

91.

Stevens LA, Levey AS. Chronic kidney disease in the elderly--how to assess risk. N Engl J Med. 2005;352(20):2122–4. https://doi.org/10.1056/NEJMe05803.CrossRefPubMed

92.

Valente MAE, Hillege HL, Navis G, Voors AA, Dunselman PHJM, Van Veldhuisen DJ, et al. The chronic kidney disease epidemiology collaboration equation outperforms the modification of diet in renal disease equation for estimating glomerular filtration rate in chronic systolic heart failure. Eur J Heart Fail. 2014;16(1):86–94. https://doi.org/10.1093/eurjhf/hft128.CrossRefPubMed

93.

Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, et al. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31. https://doi.org/10.1186/cc5713.CrossRefPubMedPubMedCentral

94.

Liu H, Sridhar VS, Lovblom LE, Lytvyn Y, Burger D, Burns K, et al. Markers of kidney injury, inflammation, and fibrosis associated with ertugliflozin in patients with CKD and diabetes. Kidney Int Rep. 2021;6(8):2095–104. https://doi.org/10.1016/j.ekir.2021.05.022.CrossRefPubMedPubMedCentral

Title: The Association Between Intra-abdominal Pressure and Diuretic Response in Heart Failure
Authors: S. Crespo-Aznarez
A. Campos-Sáenz de Santamaría
M. Sánchez-Marteles
V. Garcés-Horna
C. Josa-Laorden
I. Giménez-López
J. I. Pérez-Calvo
J. Rubio-Gracia
Publication date: 29-07-2023
Publisher: Springer US
Keywords: Heart Failure
Ultrasound
Ultrasound
Published in: Current Heart Failure Reports / Issue 5/2023
Print ISSN: 1546-9530
Electronic ISSN: 1546-9549
DOI: https://doi.org/10.1007/s11897-023-00617-x

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Purpose of the Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 5/2023

Heart Failure in the Elderly: the Role of Biological and Sociocultural Aspects Related to Sex

Perspectives on Secondary Mitral Regurgitation in Heart Failure

Natriuretic peptide receptors & heart failure

Heart failure-related iron deficiency anemia

Novel Therapeutic Strategies in Heart Failure in Adult Congenital Heart Disease: of Medicines and Devices

Do Heart Failure Biomarkers Influence Heart Failure Treatment Response?

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials